Pharma News for the week of Aug. 10, 2020

pharma world

People may become falsely optimistic that the U.S. has gotten COVID-19 under control but experts say that is because there has been a decline in testing. Texas has had a 10% drop in reported cases, but they’ve also reduced the number of people tested by 53% during that time. (CNBC)

While Vladimir Putin is trumpeting that Russia has registered the world’s first vaccine for COVID-19 (and has claimed that his daughter has been inoculated), many foreign policy and medical experts around the world are doubtful that the vaccine is viable and deliverable by November as claimed by Putin. The experts feel that this is more geared toward scoring points domestically rather than delivering a vaccine to the world. (CNBC)

Missouri has expanded Medicare coverage for thousands of people in the state. It was accomplished via mail-in ballot much to the disapproval of the Missouri Republican Party. (NPR)

The medical industry is reporting gains in non-emergency related jobs in hospitals but overall the job numbers are still down 800,000 jobs since February. (Healthcaredive)

The U.S. government has agreed to purchase 100 million doses of Moderna’s COVID-19 at $1.5 billion. The White House is touting this as a great deal, along with agreements it has with other pharmaceutical companies, “ensuring the United States has access to a successful treatment for COVID-19”. However, there are critics to this latest agreement. The advocacy group Public Citizen has come out with strongly against this agreement stating that the price is too high and the US “is being charged twice” for the shot considering that the government has already given Moderna $955 million in research funding. (Pharmaphorum)